ERA BIOLOGY Great Show at Africa Health 2022
Gallagher Convention Center, Johannesburg, South Africa – 26th-28th October – ERA BIOLOGY participated in Africa Health 2022, which is the most influent...
YY/T 1729-2020 “Fungus (1-3)-β-D-Glucan Test” formulated by Era Biology was approved by NMPA on July 9, 2020 and officially released. The standard will be formally implemented on June 1...
Global Live Webinar 20th October Waiting for you to join!
Era Biology will host a global live webinar on 20th October 2022 16:00 (GMT +08:00). The webinar will talk about the early, rapid and affor...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
Era Biology will host global live webinar at 21th June 2022 16:00 (GMT +08:00). The webinar will focus on providing comprehensive solution for invasive fungal disease diagnosis by using Full-automa...
Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...